Drug Profile
JBP 485
Alternative Names: JBP-485Latest Information Update: 05 Feb 2008
Price :
$50
*
At a glance
- Originator University of Tokyo
- Developer Japan Bioproducts Industry Company; University of Tokyo
- Class Dipeptides; Hepatoprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis; Liver disorders
Most Recent Events
- 27 Jan 2004 No development reported - Preclinical for Hepatitis in Japan (unspecified route)
- 27 Jan 2004 No development reported - Preclinical for Liver disorders prevention in Japan (unspecified route)
- 05 Sep 2001 Preclinical development for Hepatitis in Japan (Unknown route)